Production of plasmid DNA for pharmaceutical use

Biotechnology Annual Review

Volumn 13, Issue , 2007, Pages 201-222

  Voß, Carsten ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

affinity separation; capillary gel electrophoresis; cell lysis; chromatography; cultivation; gene therapy; manufacturing; plasmid; Rnase; stability.

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; PLASMID DNA; VIRUS VECTOR;

AGAR GEL ELECTROPHORESIS; ANION EXCHANGE CHROMATOGRAPHY; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CYTOLYSIS; DNA PURIFICATION; ESCHERICHIA COLI; GEL ELECTROPHORESIS; GENE ACTIVATION; GENE TRANSFER; GENETIC MANIPULATION; IMMUNOGENICITY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONVIRAL GENE DELIVERY SYSTEM; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REVIEW; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; STORAGE; TARGET CELL; ULTRAFILTRATION; ULTRAVIOLET SPECTROSCOPY; VIRAL GENE DELIVERY SYSTEM;

DRUG INDUSTRY; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; PLASMIDS; TRANSFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 34548558680     PISSN: 13872656     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1387-2656(07)13008-8     Document Type: Review

References (70)

1. Mascola J., and Nabel G. Vaccines for the prevention of HIV-1 disease. Curr Opin Immunol 13 (2001) 489-495
2. Shiver J.W., Fu T.-M., Chen L., Casimiro D.R., Davies M.-E., Evans R.K., Zhang Z.-Q., Simon A.J., Trigona W.L., Dubey S.A., et al. Replication incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 (2002) 331-335
3. Barouch D.H., Craiu A., Kuroda M.J., Schmitz J.E., Zheng X.X., Santra S., Frost J.D., Krivulka G.R., Lifton M.A., Crabbs C.L., et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci USA 97 (2002) 4192-4197
4. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.-M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., et al. Control of virimia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290 (2002) 486-492
5. Michel M.-L., Davis H.L., Schleef M., Mancini M., Tiollais P., and Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92 (1995) 5307-5311
6. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trépo C., and Inchauspé G. DNA based immunisation using chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 69 (1995) 5798-5805
7. Mountain A. Gene therapy: the first decade. Trends Biotechnol 18 (2000) 119-128
8. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., and Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
9. Wiley. Gene therapy clinical trials worldwide, 2006, http://www.wiley.co.uk/genmed/clinical/
10. Raper S.E., Yudkoff M., Chirmule N., Gao G.-P., Nunes F., Haskal Z.J., Furth E.E., Propert K.J., Robinson M.B., Magosin S., et al. A pilot study of in vivo liver directed gene transfer with adenoviral vector in partial ornitine transcarbamylase deficiency. Human Gene Ther 13 (2002) 163-175
11. Check E. Gene therapy: a tragic setback. Nature 420 (2002) 116-118
12. EMEA. Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products, CPMP/410/01 rev 1, London, 2001.
13. Schroeckh V., Hartmann M., Birch-Hirschfeld E., and Riesenberg D. Improvement of recombinant gene-expression in Escherichia coli for glucose-controlled continuous and fed-batch cultures. Appl Microbiol Biotechnol 36 (1992) 487-492
14. Horn U., Strittmatter W., Krebber A., Knüpfer U., Kujau M., Wenderoth R., Müller K., Matzku S., Plückthun A., and Riesenberg D. High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl Microbiol Biotechnol 46 (1996) 524-532
15. Wang F., and Lee S.Y. High cell density culture of metabolically engineered Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium. Biotechniol Bioeng 58 (1998) 325-328
16. Lee S.Y., and Chang H.N. High cell density cultivation of Escherichia coli using sucrose as a carbon source. Biotechnol Lett 15 (1994) 971-974
17. Nakano K., Rischke M., Sato S., and Märkl H. Influence of acetic acid on the growth of Escherichia coli K12 during high-cell-density cultivation in a dialysis reactor. Appl Microbiol Biotechnol 48 (1997) 597-601
18. Schmidt T., Schleef M., Friehs K., and Flaschel E. Hochzelldichtefermentation zur Gewinnung von Plasmid-DNA für Gentherapie und genetische Impfung. BIOforum 22 (1999) 174-177
19. Macaloney G., Hall J.W., Rollins M.J., Draper I., Anderson K.B., Preston J., Thompson B.G., and McNeil B. The utility and performance of near-infrared spectroscopy in simultaneous monitoring multiple components in a high cell density recombinant Escherichia coli production process. Bioprocess Eng 17 (1997) 157-167
20. Paalme T., Tiisma K., Kahru A., Vanatalu K., and Vilu R. Glucose-limited fed-batch cultivation of Escherichia coli with computer-controlled fixed growth rate. Biotechnol Bioeng 35 (1990) 312-319
21. Reinikainen P., Korpela K., Nissinen V., Olkku J., Söderlund H., and Markkanen P. Escherichia coli plasmid production in fermenter. Biotechnol Bioeng 33 (1989) 386-393
22. Lahijani R., Hulley G., Soriano G., Horn N.A., and Marquet M. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum Gene Ther 7 (1996) 1971-1980
23. Voss C., Schmidt T., Schleef M., Friehs K., and Flaschel E. Effect of ammonium chloride on plasmid DNA production in high cell density batch culture for biopharmaceutical use. J Chem Technol Biotechnol 79 (2004) 57-62
24. Levy M.S., O'Kennedy R.D., Ayazi-Shamlou P., and Dunnill P. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends Biotechnol 18 (2000) 296-305
25. Birnboim H.C., and Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7 (1979) 1513-1523
26. Ciccolini L.A.S., Shamlou P.A., Titchener-Hooker N.J., Ward J.M., and Dunnill P. Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release. Biotechnol Bioeng 60 (1998) 768-770
27. Theodossiou I., Collins I.J., Ward J.M., Thomas O.R.T., and Dunnill P. The processing of a plasmid-based gene from E. coli. Primary recovery by filtration. Bioprocess Eng 16 (1997) 175-183
28. Theodossiou I., Thomas O.R.T., and Dunnill P. Methods of enhancing the recovery of plasmid genes from neutralised cell lysate. Bioprocess Eng 20 (1999) 147-156
29. Wan NC, McNeilly DS and Christopher CW. Method for lysing cells, US Patent 5 837 529, 1998.
30. Wright J.L., Jordan M., and Wurm F.M. Extraction of plasmid DNA using reactor scale alkaline lysis and selective precipitation for scalable transient transfection. Cytotechnology 35 (2001) 165-173
31. Voß C., Schmidt T., and Schleef M. From bulk to delivery: plasmid manufacturing and storage. In: Schleef M. (Ed). DNA Pharmaceuticals (2005), Wiley-VCH, Weinheim, Germany
32. Holmes D., and Quigley M. A rapid boiling method for the preparation of bacterial plasmids. Anal Biochem 114 (1981) 193-197
33. Lee AL and Sagar S. A method for large scale plasmid purification, WO 96/36706, 1999.
34. O'Mahony K., Freitag R., Hilbrig F., Müller P., and Schumacher I. Proposal for a better integration of bacterial lysis into the production of plasmid DNA at large scale. J Biotechnol 119 (2005) 118-132
35. Zhu K., Jin H., Ma Y., Ren Z., Xiao C., He Z., Zhang F., Zhu Q., and Wang B. A continuous thermal lysis procedure for the large-scale preparation of plasmid DNA. J Biotechnol 118 (2005) 257-264
36. Stadler J., Lemmens R., and Nyhammar T. Plasmid DNA purification. J Gene Med 6 (2004) S54-S66
37. Ljunglöf A., Bergvall P., Bhikhabhai R., and Hjorth R. Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy. J Chromatogr A 844 (1999) 129-135
38. FDA. Guidance for Industry: Guidance for Human Somatic Cell Therapy and Gene Therapy (1998), Center for Biologics Evaluation and Research, FDA, Rockville, MD
39. EMEA. Safety studies for gene therapy products, CPMP/SWP/112/98 draft, London, 1998.
40. Schorr J., Moritz P., and Schleef M. Production of plasmid DNA in industrial quantities accorging to cGMP guidelines. In: Lowrie D.B., and Whalen R.G. (Eds). DNA Vaccines: Methods and Protocols (1999), Humana Press, Totowa, NJ 11-21
41. Bussey L, Adamson R and Atchley A. Methods for purifying nucleic acids, WO 98/05673, 1998.
42. Eon-Duval A., Gumbs K., and Ellett C. Precipitation of RNA impurities with high salt in a plasmid DNA purification process: use of experimental design to determine reaction conditions. Biotechnol Bioeng 83 (2003) 544-553
43. Horn N, Budahazi G and Marquet M. Purification of plasmid DNA during column chromatography, US 5 707 812, 1998.
44. Costioli M.D., Fisch I., Garret-Flaudy F., Hilbrig F., and Freitag R. DNA purification by triple-helix affinity precipitation. Biotechnol Bioeng 81 (2003) 535-545
45. Murphy J.C., Wibbenmeyer J.A., Fax G.E., and Willson R.C. Purification of plasmid DNA using selective precipitation by compaction agents. Nature Biotchnol 17 (1999) 822-823
46. Lander R.J., Winters M.A., Meacle F.J., Buckland B.C., and Lee A.L. Fractional precipitation of plasmid DNA from lysate by CTAB. Biotechnol Bioeng 79 (2002) 776-784
47. Ribeiro S.C., Monteiro G.A., Cabral J.M.S., and Prazeres D.M.F. Isolation of plasmid DNA from cell lysates by aqueous two-phase systems. Biotechnol Bioeng 78 (2002) 376-384
48. Kepka C., Lemmens R., Vasi J., Nyhammar T., and Gustavsson P.-E. Integrated process for purification of plasmid DNA using aqueous two-phase systems combined with membrane filtration and lid bead chromatography. J Chromatogr A 1057 (2004) 115-124
49. Hatton T.A. Reversed micellar extraction of proteins. In: Scamehorn J.F., and Harwell J.H. (Eds). Surfactant-Based Separation Processes (1989), Marcel Dekker Inc., New York
50. Goto M., Ono T., Horiuchi A., and Furusaki S. Extraction of DNA by reversed micelles. J Chem Eng Japan 32 (1999) 123-125
51. Voß C. Innovative Prozessstrategien zur Herstellung von Plasmid-DNA als Wirkstoff. BIOforum 9 (2004) 38-39
52. Colpan M, Schorr J and Moritz P. Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy, WO 95/21177, 1995.
53. Lemmens R., Olsson U., Nyhammar T., and Stadler J. Supercoiled plasmid DNA: selective purification by thiophilic/aromatic adsorption. J Chromatogr B 784 (2003) 291-300
54. Diogo M.M., Queiroz J.A., and Prazeres D.M.F. Studies on the retention of plasmid DNA and Escherichia coli nucleic acids by hydrophobic interaction chromatography. Bioseparation 10 (2001) 211-220
55. Eon-Duval A., MacDuff R.H., Fisher C.A., Harris M.J., and Brook C. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process. Anal Biochem 316 (2003) 66-73
56. Gustavsson P.-E., Lemmens R., Nyhammar T., Busson P., and Larsson P.-O. Purification of plasmid DNA with a new type of anion-exchange beads having a non-charged surface. J Chromatogr A 1038 (2004) 131-140
57. Murphy J.C., Jewell D.L., White K.I., Fox G.E., and Willson R.C. Nucleic acid separations utilizing immobilized metal affinity chromatography. Biotechnol Prog 19 (2003) 982-986
58. Schluep T., and Cooney C.L. Purification of plasmids by triplex interaction. Nucleic Acids Res 26 (1998) 4524-4528
59. Woodgate J., Palfrey D., Nagel D.A., Hine A.V., and Slater N.K.H. Protein-mediated isolation of plasmid-DNA by a zinc finger-glutathione S-transferase affinity linker. Biotechnol Bioeng 79 (2002) 450-456
60. Ghose S., Forde G.M., and Slater N.K.H. Affinity adsorption of plasmid DNA. Biotechnol Prog 20 (2004) 841-850
61. Lundeberg J., Wahlberg J., and Uhlen M. Affinity purification of specific DNA fragments using a lac repressor fusion protein. Genet Anal Tech Appl 7 (1990) 47-52
62. Kumar A., Galaev I.Y., and Mattiasson B. Purification of Lac repressor protein using polymer displacement and immobilization of the protein. Bioseparation 8 (1999) 307-316
63. Hasche A., and Voß C. Immobilisation of a repressor protein for binding of plasmid DNA. J Chromatogr A 1080 (2005) 76-82
64. Strancar A., Podgornik A., Barut M., and Necina R. Short monlithic columns as stationary phases for biochromatography. Adv Biochem Eng Biotechnol 76 (2002) 49-85
65. Giovannini R., Freitag R., and Tennikova T.B. High-performance membrane chromatography of supercoiled plasmid DNA. Anal Chem 70 (1998) 3348-3354
66. Urthaler J., Schlegl R., Podgornik A., Strancar A., Jungbauer A., and Necina R. Application of monoliths for plasmid DNA purification Development and transfer to production. J Chromatogr A 1065 (2005) 93-106
67. Voss C., Lindau D., and Flaschel E. Production of recombinant RNase Ba and its application in downstream processing of plasmid DNA for pharmaceutical use. Biotechnol Prog 22 (2006) 737-744
68. Schmidt T., Friehs K., Schleef M., Voss C., and Flaschel E. Quantitative analysis of plasmid forms by agarose and capillary gel electrophoresis. Anal Biochem 274 (1999) 235-240
69. Walther W., Stein U., Voss C., Schmidt T., Schleef M., and Schlag P.M. Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer. Anal Biochem 318 (2003) 230-235
70. Walther W., Stein U., Fichtner I., Voß C., Schmidt T., Schleef M., Nellessen T., and Schlag P.M. Intratumoral low volume jet-injection for efficient non-viral gene transfer. Mol Biotechnol 21 (2002) 105-115